| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Alberto Fernández, Juan Manuel García-Segura, Tomás Ortiz, Julia Montoya, Fernando Maestú, Pedro Gil-Gregorio, Pablo Campo, Juan Viañ. Proton magnetic resonance spectroscopy and magnetoencephalographic estimation of delta dipole density: a combination of techniques that may contribute to the diagnosis of Alzheimer's disease. Dementia and geriatric cognitive disorders. vol 20. issue 2-3. 2005-10-13. PMID:16020946. |
proton magnetic resonance spectroscopy and magnetoencephalographic estimation of delta dipole density: a combination of techniques that may contribute to the diagnosis of alzheimer's disease. |
2005-10-13 |
2023-08-12 |
Not clear |
| Rena Li, Ron Strohmeyer, Zhe Liang, Lih-Fen Lue, Joseph Roger. CCAAT/enhancer binding protein delta (C/EBPdelta) expression and elevation in Alzheimer's disease. Neurobiology of aging. vol 25. issue 8. 2004-10-04. PMID:15212823. |
ccaat/enhancer binding protein delta (c/ebpdelta) expression and elevation in alzheimer's disease. |
2004-10-04 |
2023-08-12 |
human |
| Bhagu R Bhavnan. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's. The Journal of steroid biochemistry and molecular biology. vol 85. issue 2-5. 2003-10-29. PMID:12943738. |
because estrogens such as the delta(8)-estrogens are relatively less feminizing than the classical estrogen 17beta-estradiol, they may be important in the development of more neuro-specific estrogens that will be useful in the prevention of neurodegenerative diseases, such as alzheimer's and parkinson disease, in both men and women. |
2003-10-29 |
2023-08-12 |
human |
| Alberto Fernández, Juan Arrazola, Fernando Maestú, Carlos Amo, Pedro Gil-Gregorio, Christian Wienbruch, Tomás Orti. Correlations of hippocampal atrophy and focal low-frequency magnetic activity in Alzheimer disease: volumetric MR imaging-magnetoencephalographic study. AJNR. American journal of neuroradiology. vol 24. issue 3. 2003-06-11. PMID:12637301. |
patients with alzheimer disease (ad) have more low-frequency activity on conventional eeg and increased focal magnetoencephalographic (meg) dipole density (dd) in delta and theta bands. |
2003-06-11 |
2023-08-12 |
Not clear |
| Alberto Fernández, Fernando Maestú, Carlos Amo, Pedro Gil, Thorsten Fehr, Christian Wienbruch, Brigitte Rockstroh, Thomas Elbert, Tomás Orti. Focal temporoparietal slow activity in Alzheimer's disease revealed by magnetoencephalography. Biological psychiatry. vol 52. issue 7. 2002-12-20. PMID:12372668. |
patients suffering from alzheimer's disease exhibit more activity in the conventional electroencephalographic delta and theta bands. |
2002-12-20 |
2023-08-12 |
Not clear |
| A Stevens, T Kircher, M Nickola, M Bartels, N Rosellen, H Wormstal. Dynamic regulation of EEG power and coherence is lost early and globally in probable DAT. European archives of psychiatry and clinical neuroscience. vol 251. issue 5. 2002-07-09. PMID:11829205. |
electroencephalographic (eeg) findings in dementia of alzheimer type (dat) include slowing of alpha frequency, loss of alpha band power, increased theta and delta power and reduced coherence. |
2002-07-09 |
2023-08-12 |
Not clear |
| A M Mathieu-Kia, L Q Fan, M J Kreek, E J Simon, J M Hille. Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients. Brain research. vol 893. issue 1-2. 2001-06-21. PMID:11223000. |
the putative role of the opioid system in cognitive and memory functions prompted us to search for possible changes in the cohort of the major opioid receptors, mu, delta and kappa, in alzheimer's disease. |
2001-06-21 |
2023-08-12 |
Not clear |
| V Vogelsberg-Ragaglia, T Schuck, J Q Trojanowski, V M Le. PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Experimental neurology. vol 168. issue 2. 2001-05-10. PMID:11259128. |
since abnormal tau phosphorylation may play a role in neurofibrillary tangle (nft) formation in aging and alzheimer's disease (ad), we probed the distribution and abundance of protein phosphatase 2a (pp2a) catalytic (calpha) and regulatory (pr55alpha and gamma, pr61varepsilon and delta) subunit mrna in control and ad hippocampus using in situ hybridization. |
2001-05-10 |
2023-08-12 |
Not clear |
| C Schwab, A J DeMaggio, N Ghoshal, L I Binder, J Kuret, P L McGee. Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases. Neurobiology of aging. vol 21. issue 4. 2000-09-07. PMID:10924763. |
the distribution of casein kinase 1 delta (cki delta) was studied by immunohistochemistry and correlated with other pathological hallmarks in alzheimer's disease (ad), down syndrome (ds), progressive supranuclear palsy (psp), parkinsonism dementia complex of guam (pdc), pick's disease (pid), pallido-ponto-nigral degeneration (ppnd), parkinson's disease (pd), dementia with lewy bodies (dlb), amyotrophic lateral sclerosis (als), and elderly controls. |
2000-09-07 |
2023-08-12 |
Not clear |
| C Fornara, M Cursi, L Roveri, F Minicucci, T Locatelli, G Com. FFT approximation in Alzheimer's disease. Italian journal of neurological sciences. vol 19. issue 4. 2000-08-29. PMID:10933459. |
in this study, the fast fourier transform (fft) approximation was used to characterise modifications in the electroencephalogram location or orientation of the source of the dipole equivalent of the delta, theta, alpha1, alpha2, beta1 and beta2 frequencies in 20 with patients with alzheimer's disease and in a control group of 20 age-matched subjects. |
2000-08-29 |
2023-08-12 |
human |
| K Yasojima, J Kuret, A J DeMaggio, E McGeer, P L McGee. Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain. Brain research. vol 865. issue 1. 2000-07-21. PMID:10814741. |
casein kinase 1 delta mrna is upregulated in alzheimer disease brain. |
2000-07-21 |
2023-08-12 |
Not clear |
| A F Greenwood, R E Powers, R S Jop. Phosphoinositide hydrolysis, G alpha q, phospholipase C, and protein kinase C in post mortem human brain: effects of post mortem interval, subject age, and Alzheimer's disease. Neuroscience. vol 69. issue 1. 1996-07-08. PMID:8637611. |
influences of post mortem time interval, subject age and alzheimer's disease were investigated on several components of the phosphoinositide second messenger system, including stimulation of [3h]phosphatidylinositol hydrolysis by gtp[s] and several receptor agonists and the levels of galphaq, beta, delta and gamma subtypes of phospholipase c, and five protein kinase c isoforms, in membranes prepared from post mortem human prefrontal cortex. |
1996-07-08 |
2023-08-12 |
human |
| U Fisze. [Role of gamma-delta T-cells and heat shock proteins in immunological response and in pathogenesis of neurological diseases]. Neurologia i neurochirurgia polska. vol 29. issue 5. 1996-03-18. PMID:8584100. |
results of the studies suggest participation of gamma delta t cells and hsps in pathogenesis of certain diseases, including neurological ones (multiple sclerosis, alzheimer's disease, parkinson's disease and cerebrovascular diseases), although detailed explanation of this problem requires further studies. |
1996-03-18 |
2023-08-12 |
Not clear |
| M Heilig, M Sjögren, K Blennow, R Ekman, A Walli. Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia. Biological psychiatry. vol 38. issue 4. 1996-02-20. PMID:8547442. |
we have examined the levels of corticotropin-releasing hormone (crh), beta-endorphine (bend), delta sleep-inducing peptide (dsip), somatostatin (srif), and neuropeptide y (npy) in csf samples obtained under highly standardized conditions from healthy aged controls and from patients suffering from alzheimer's disease (ad) or vascular dementia (vad). |
1996-02-20 |
2023-08-12 |
Not clear |
| D C Valladares-Neto, M S Buchsbaum, W J Evans, D Nguyen, P Nguyen, B V Siegel, J Stanley, A Starr, S Guich, D Ric. EEG delta, positron emission tomography, and memory deficit in Alzheimer's disease. Neuropsychobiology. vol 31. issue 4. 1995-10-05. PMID:7659198. |
patients with alzheimer's disease had significantly greater left temporal delta amplitude and lower glucose metabolic rates. |
1995-10-05 |
2023-08-12 |
human |
| D C Valladares-Neto, M S Buchsbaum, W J Evans, D Nguyen, P Nguyen, B V Siegel, J Stanley, A Starr, S Guich, D Ric. EEG delta, positron emission tomography, and memory deficit in Alzheimer's disease. Neuropsychobiology. vol 31. issue 4. 1995-10-05. PMID:7659198. |
eeg delta, positron emission tomography, and memory deficit in alzheimer's disease. |
1995-10-05 |
2023-08-12 |
human |
| J Seelig, R Lehrmann, E Terz. Domain formation induced by lipid-ion and lipid-peptide interactions. Molecular membrane biology. vol 12. issue 1. 1995-07-05. PMID:7767383. |
the binding of alzheimer peptide fragments to the lipid membrane is accompanied by an exothermic heat of reaction with delta h in the range -2 - -8 kcal/mol. |
1995-07-05 |
2023-08-12 |
Not clear |
| M Zebrower, C Beeber, F J Kiera. Characterization of proteoglycans in Alzheimer's disease fibroblasts. Biochemical and biophysical research communications. vol 184. issue 3. 1992-06-23. PMID:1590792. |
delta ua-glcns was increased by 30% while delta ua-glcns-6s was reduced by 40% in alzheimer's disease. |
1992-06-23 |
2023-08-11 |
Not clear |
| A Degrand-Guillaud, Y Obadia, J Guélai. [Survey methodology in the prevalence of Alzheimer's disease in the Rhône delta]. Revue d'epidemiologie et de sante publique. vol 39. issue 4. 1992-01-30. PMID:1754706. |
[survey methodology in the prevalence of alzheimer's disease in the rhône delta]. |
1992-01-30 |
2023-08-11 |
Not clear |
| D B Hier, C A Mangone, R Ganellen, J D Warach, R Van Egeren, S J Perlik, P B Gorelic. Quantitative measurement of delta activity in Alzheimer's disease. Clinical EEG (electroencephalography). vol 22. issue 3. 1991-10-02. PMID:1879056. |
however, delta activity was a significantly greater percentage of total eeg power in the moderate-to-advanced alzheimer's subjects when compared to either the healthy controls or mild alzheimer subjects. |
1991-10-02 |
2023-08-11 |
human |